Traitement chirurgical du carcinome hépatocellulaire : les recommandations actuelles sont-elles trop restrictives ? [Current surgical treatment for hepatocellular carcinoma : critical appraisal of current guidelines]
Fiche du document
14 juin 2017
- handle: 10670/1.3u78kg
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/28643982
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_29F061D1FFE92
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
RN 7440-65-5 Sciences de la gestion Gestion, Sciences de la Sciences de gestion Techniques de gestion Direction ManagementCiter ce document
D. Clerc et al., « Traitement chirurgical du carcinome hépatocellulaire : les recommandations actuelles sont-elles trop restrictives ? [Current surgical treatment for hepatocellular carcinoma : critical appraisal of current guidelines] », Serveur académique Lausannois, ID : 10670/1.3u78kg
Métriques
Partage / Export
Résumé
Hepatocellular carcinoma (HCC) management has evolved in the last decades. Current available treatments include interventional radiology like radiofrequency ablation, transarterial chemoembolization or Yttrium 90 radioembolization. Surgery, when possible, has been proven to be the most effective treatment in reducing the risk of long-term local recurrence. American and European societies (AASLD, EASL, respectively) guidelines for the management of HCC endorse The Barcelona Clinic Liver Cancer (BCLC) treatment allocation system. One drawback of the BCLC system is its restrictiveness regarding surgical indications. This present article aims in reviewing the indications of surgical resection for HCC.